We are joining the National Institute for Health and Care Research (NIHR) in celebrating International Clinical Trials Day 2022 and saying thank you to all those involved in clinical trials.

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation (MA) for a new treatment for HR+ and HER2- breast cancer patients at high risk of recurrence, following results from a study led by Royal Marsden researchers.

Infertile men may be twice as likely to develop breast cancer than those without fertility issues, according to new research published this month.

We are delighted to announce that applications are now open for Mentees to submit their request to take part in this year’s BRC Clinical Academic Mentoring Scheme, a joint ICR-RM initiative which seeks to support the academic career progression of clinician researchers.

Bernard Siu, a research nurse at The Royal Marsden NHS Foundation Trust, has spoken about the many benefits of working in research to mark International Nurses Day (Thursday 12 May).

The Institute of Cancer Research, London, has rated second in REF 2021 – the Government’s evaluation of university research quality – among all higher education institutions in the UK that submitted at least two units of assessment.

Professor Kristian Helin, Chief Executive at The Institute of Cancer Research (ICR), and Professor Trevor Graham, Director of the ICR's Centre for Evolution and Cancer, have been awarded prestigious Fellowships by the Academy of Medical Sciences (AMS).

Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to a study led by researchers from The Royal Marsden NHS Foundation Trust in collaboration with The Institute of Cancer Research, London, and Imperial College London.

A group of UK clinical and non-clinical scientists working together across different areas of cancer research has won one of the world’s most prestigious team science awards for work that has transformed treatment for many patients with breast cancer.

A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials.